Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $38.39 million
- Book Value:
- Revenue TTM:
- $69.77 million
- Operating Margin TTM:
- Gross Profit TTM:
- $68.11 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
TherapeuticsMD Inc had its IPO on 2003-12-11 under the ticker symbol TXMD.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. TherapeuticsMD Inc has a staff strength of 1 employees.
Shares of TherapeuticsMD Inc opened at $3.59 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $3.59 - $3.72, and closed at $3.62.
This is a -0.28% slip from the previous day's closing price.
A total volume of 21,485 shares were traded at the close of the day’s session.
In the last one week, shares of TherapeuticsMD Inc have slipped by -4.23%.
TherapeuticsMD Inc's Key Ratios
TherapeuticsMD Inc has a market cap of $38.39 million, indicating a price to book ratio of 40.7475 and a price to sales ratio of 0.7174.
In the last 12-months TherapeuticsMD Inc’s revenue was $69.77 million with a gross profit of $68.11 million and an EBITDA of $38.99 million. The EBITDA ratio measures TherapeuticsMD Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, TherapeuticsMD Inc’s operating margin was 54.83% while its return on assets stood at 23.92% with a return of equity of 11.34%.
In Q2, TherapeuticsMD Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 25.6%.
TherapeuticsMD Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $3.37 per share while it has a forward price to earnings multiple of 2.291 and a PEG multiple of -0.73. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into TherapeuticsMD Inc’s profitability.
TherapeuticsMD Inc stock is trading at a EV to sales ratio of 1.6199 and a EV to EBITDA ratio of 17.5384. Its price to sales ratio in the trailing 12-months stood at 0.7174.
TherapeuticsMD Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $53.69 million
- Total Liabilities
- $14.36 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
TherapeuticsMD Inc ended 2023 with $53.69 million in total assets and $0 in total liabilities. Its intangible assets were valued at $53.69 million while shareholder equity stood at $31.20 million.
TherapeuticsMD Inc ended 2023 with $0 in deferred long-term liabilities, $14.36 million in other current liabilities, 11000.00 in common stock, $-945380000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $13.73 million and cash and short-term investments were $13.73 million. The company’s total short-term debt was $1,448,000 while long-term debt stood at $0.
TherapeuticsMD Inc’s total current assets stands at $19.61 million while long-term investments were $0 and short-term investments were $68410.00. Its net receivables were $1.04 million compared to accounts payable of $1.51 million and inventory worth $3.40 million.
In 2023, TherapeuticsMD Inc's operating cash flow was $0 while its capital expenditure stood at $10000.
Comparatively, TherapeuticsMD Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
TherapeuticsMD Inc stock is currently trading at $3.62 per share. It touched a 52-week high of $8.67 and a 52-week low of $8.67. Analysts tracking the stock have a 12-month average target price of $5.
Its 50-day moving average was $3.94 and 200-day moving average was $4.43 The short ratio stood at 16.02 indicating a short percent outstanding of 0%.
Around 818.3% of the company’s stock are held by insiders while 4469% are held by institutions.
Frequently Asked Questions About TherapeuticsMD Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.